The Institutional Review Board (IRB) at People’s Liberation Army Hospital (301 Hospital, Beijing) approved the clinical trial of Stem Cell Educator therapy for the treatment of diabetic patients. Dr.Yong Zhao at Hackensack University Medical Center (New Jersey, USA) is collaborating with Dr.Yiming Mu at the Section of Endocrinology (Beijing, China) to explore the molecular mechanisms underlying the insulin resistance in type 2 diabetes. This project has been supported by National Natural Science Foundation of China. The previous study has demonstrated the safety and clinical efficacy of Stem Cell Educator therapy for the treatment of type 2 diabetes.